Awardee OrganizationUNIVERSITY OF SOUTH CAROLINA AT COLUMBIA
Description
Abstract Text
Abstract
Language impairments can vary considerably between individuals with aphasia. Our neurobiological
models based on the stroke lesion can only partly explain the aphasic symptoms. We hypothesize that the
integrity of the residual brain tissue outside the stroke lesion is an important, but not yet fully appreciated,
determinant of aphasia severity and recovery.
It is well recognized that cardiovascular risk factors lead to cumulative widespread brain damage
through small vessel disease (SVD). Outside the aphasia literature, SVD has been strongly associated with
poor cognitive reserve and reduced resiliency to various forms of neurological injury. Stroke survivors with
aphasia typically have cardiovascular risk factors and they commonly exhibit SVD. However, the impact of
SVD is not usually taken into account in our models of recovery, even though the residual brain tissue is
responsible for overcoming the loss of function. It follows that higher degrees of SVD outside the lesion may
lead to worse aphasic symptoms and less chances of recovery due to reduced capacity to compensate for the
stroke injury. Our goal is to directly test this hypothesis.
We propose to evaluate how aphasia is shaped by the stroke lesion in combination with residual brain
integrity. Neuroimaging (brain MRI) is ideally suited to address this problem. SVD is composed of
microangiopathic ischemic changes and microhemorrhages. The ischemic changes from SVD can be
measured through white matter hyper intensities using T2-weighted and T2-FLAIR images, and the
microhemorrhages can be assessed using susceptibility-weighted images. SVD preferentially affects white
matter and diffusion MRI can provide additional measures of white matter microstructural integrity and their
relationship with the whole brain neuronal networks architecture (the brain connectome).
Using our experience with post-stroke lesion symptom mapping, white matter and connectome imaging
we propose a comprehensive study of the neurobiology and impact of SVD in aphasia. Our project will build on
international guidelines for SVD assessment (The STandards for ReportIng Vascular changes on
nEuroimaging - STRIVE) and it will develop an innovative multimodal machine learning approach to fully
assess brain integrity.
Brain integrity and language measures will be assessed in the context of chronic (Project 1) and acute
(Project 2) aphasia recovery. The behavioral and linguistic assessments will be guided by Project 4. With the
neuroimaging core, we will develop and distribute a multimodal neuroimaging approach to quantify the severity
and location of SVD.
Specific Aim 1 will longitudinally assess the independent impact of SVD, controlling for the brain lesion,
on acute and chronic symptoms, as well as acute and chronic language recovery. Specific Aim 2 will evaluate
the mechanisms by which SVD leads to language impairments by assessing the impact of SVD and stroke
lesions on connectome neural network architecture, loss of associative long-range white matter fibers and its
relationship with semantic, lexical-semantic, lexical-phonological, phonological/phonetic deficits.
National Institute on Deafness and Other Communication Disorders
CFDA Code
DUNS Number
041387846
UEI
J22LNTMEDP73
Project Start Date
01-April-2016
Project End Date
31-March-2026
Budget Start Date
01-April-2024
Budget End Date
31-March-2025
Project Funding Information for 2024
Total Funding
$165,770
Direct Costs
$123,497
Indirect Costs
$42,273
Year
Funding IC
FY Total Cost by IC
2024
National Institute on Deafness and Other Communication Disorders
$165,770
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 5P50DC014664-09 7902
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 5P50DC014664-09 7902
Patents
No Patents information available for 5P50DC014664-09 7902
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 5P50DC014664-09 7902
Clinical Studies
No Clinical Studies information available for 5P50DC014664-09 7902
News and More
Related News Releases
No news release information available for 5P50DC014664-09 7902
History
No Historical information available for 5P50DC014664-09 7902
Similar Projects
No Similar Projects information available for 5P50DC014664-09 7902